NOT KNOWN FACTS ABOUT RESEARCH CHEMICALS UK

Tirzepatide remaining a dual GLP-1 and GIP agonist, it is instructed that the GIP ingredient of dual agonism could be to blame for the additional advantage, provided the possible advantage of GIP receptor agonism on peripheral insulin sensitization. Therefore, tirzepatide was more effective than dulaglutide in minimizing fasting dietary TAG [6,7].